These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8881897)

  • 41. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. Aa double-blind, single-centre, cross-over pilot study.
    Zurbriggen B; Wüthrich B; Cachelin AB; Wili PB; Kägi MK
    Dermatology; 1999; 198(1):56-60. PubMed ID: 10026403
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis.
    Heydendael VM; Spuls PI; Opmeer BC; de Borgie CA; Reitsma JB; Goldschmidt WF; Bossuyt PM; Bos JD; de Rie MA
    N Engl J Med; 2003 Aug; 349(7):658-65. PubMed ID: 12917302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study.
    Berth-Jones J; Henderson CA; Munro CS; Rogers S; Chalmers RJ; Boffa MJ; Norris PG; Friedmann PS; Graham-Brown RA; Dowd PM; Marks R; Sumner MJ
    Br J Dermatol; 1997 Apr; 136(4):527-30. PubMed ID: 9155952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of cyclosporin in a patient with hepatitis C and pustular psoriasis.
    Bomm L; Zimmermann CC; Souto R; Bressan A; Gripp A
    An Bras Dermatol; 2011; 86(4 Suppl 1):S193-5. PubMed ID: 22068808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
    Coukell AJ; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy.
    Harper JI; Ahmed I; Barclay G; Lacour M; Hoeger P; Cork MJ; Finlay AY; Wilson NJ; Graham-Brown RA; Sowden JM; Beard AL; Sumner MJ; Berth-Jones J
    Br J Dermatol; 2000 Jan; 142(1):52-8. PubMed ID: 10651694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of ciclosporin in psoriasis.
    Berth-Jones J
    J Dermatolog Treat; 2005; 16(5-6):258-77. PubMed ID: 16428145
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Extreme rises in serum alkaline phosphatase in children with atopic dermatitis after intervention treatment with cyclosporin A.
    van Meurs T; Wolkerstorfer A; Oranje AP
    Pediatr Dermatol; 1998; 15(6):483. PubMed ID: 9875977
    [No Abstract]   [Full Text] [Related]  

  • 49. Neoral: the new cyclosporine.
    Corbett J; Ross K
    ANNA J; 1998 Feb; 25(1):71-2. PubMed ID: 9543913
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of cyclosporin in a child with generalized pustular psoriasis.
    Alli N; Güngör E; Karakayali G; Lenk N; Artüz F
    Br J Dermatol; 1998 Oct; 139(4):754-5. PubMed ID: 9892934
    [No Abstract]   [Full Text] [Related]  

  • 51. Cyclosporin A-induced gingival hyperplasia in psoriasis: review of the literature and case reports.
    V'lckova-Laskoska MT
    Acta Dermatovenerol Croat; 2005; 13(2):108-13. PubMed ID: 16324424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis.
    Actis GC; Lagget M; Rizzetto M; Fadda M; Palmo A; Pinna-Pintor M; Morino F
    Minerva Med; 2004 Feb; 95(1):65-70. PubMed ID: 15041927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Generalized pustular psoriasis during pregnancy: an effective treatment with cyclosporin].
    Harvima RJ; Laukkanen A; Haring P; Rinne K
    Duodecim; 1999; 115(4):391-5. PubMed ID: 11830887
    [No Abstract]   [Full Text] [Related]  

  • 54. Cyclosporine in Dermatology.
    Kutlubay Z; Erdogan BÇ; Engin B; Serdaroglu S
    Skinmed; 2016; 14(2):105-9. PubMed ID: 27319953
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cyclosporin versus etretinate: Italian multicenter comparative trial in severe plaque-form psoriasis. Italian Multicenter Study Group on Cyclosporin in Psoriasis.
    Dermatology; 1993; 187 Suppl 1():8-18. PubMed ID: 8369579
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tazarotene Revisited: Safety and Efficacy in Plaque Psoriasis and Its Emerging Role in Treatment Strategy.
    Tanghetti E; Lebwohl M; Stein Gold L
    J Drugs Dermatol; 2018 Dec; 17(12):1280-1287. PubMed ID: 30586259
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M; Gül M; Seyhan M
    Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Real world experience using Ciclosporin in psoriasis: Efficacy and toxicity in the Australasian Psoriasis Registry.
    Berry W; Daniel BS; Baker C; Foley P
    Australas J Dermatol; 2020 Nov; 61(4):380-382. PubMed ID: 32367517
    [No Abstract]   [Full Text] [Related]  

  • 59. The FDA guidelines for the treatment of psoriasis using cyclosporine A: are they adequate?
    Zackheim HS
    Cutis; 2002 Nov; 70(5):288-90. PubMed ID: 12469783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pustular psoriasis exacerbated by pregnancy and controlled by cyclosporin A.
    Finch TM; Tan CY
    Br J Dermatol; 2000 Mar; 142(3):582-4. PubMed ID: 10777276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.